Robert Malone on covid: what the evidence says · JRE #2454

What the evidence says 01 / RECORD

Cochrane's living systematic review of ivermectin for COVID-19, most recently updated through April 2022 and published June 2022, concluded there was no evidence to support ivermectin for treating or preventing COVID-19: moderate-certainty evidence of no mortality benefit in outpatients, high-certainty evidence of no effect on quality of life in outpatients, and very-low-certainty, uncertain evidence on mortality in hospitalized patients. Cochrane explains that, as a living review, its conclusions are updated as trial evidence accumulates, and it explicitly states it held no prior belief about ivermectin's effectiveness; it does not describe any suppression by outside influence. Separately, a widely publicized ivermectin meta-analysis by Hill et al., published July 2021 in Open Forum Infectious Diseases and initially reported to show a survival signal, was formally retracted later that year because one of its largest contributing studies (Elgazzar et al.) was withdrawn for containing fraudulent data, with additional quality problems identified in other included trials, not because of any unspecified outside influence. No allowlisted source documents a meta-analysis that showed ivermectin was highly effective being deliberately squashed by external influence; the documented cases involve either evidence-based revision (Cochrane) or retraction due to identified data fraud (Hill et al.). The claim's account of what happened and why is therefore misleading.